Managing the risk of wound tetanus in family practice

被引：4

作者：

Barjat, C. ^{[1
]}

Charles, R. ^{[1
]}

Lucht, F. ^{[2
]}

Frappe, P. ^{[1
]}

机构：

[1] Fac Med Jacques Lisfranc, Serv Univ Med Gen, F-42023 St Etienne 2, France

[2] CHU St Etienne, Serv Malad Infect & Trop CIC EC3, F-42277 St Priest En Jarez, France

来源：

MEDECINE ET MALADIES INFECTIEUSES | 2011年 / 41卷 / 08期

关键词：

Family practice; Tetanus; Wounds; EMERGENCY-DEPARTMENT;

D O I：

10.1016/j.medmal.2010.12.014

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Objectives. - The study objectives were to assess how GPs manage the risk of tetanus in wounds, compared to the French Health Ministry guidelines on tetanus toxoid vaccination and immunoglobulin injections. Design. - A cross-sectional survey was made using an online questionnaire sent to 3,165 GPs in the French Rhone-Alpes region. Results. - The answer rate was 9.1%. Overall, 64.4% of GP complied to recommendations. The best observance was noted for minor risk wounds and for patients whose last booster vaccination was less than 5 years old (P < 0.05). Generally, GPs underused tetanus toxoid vaccination (-17.1%) and overused immunoglobulin injections (+37.1%). The main difficulties encountered were assessing the patient and his wound, misuse of immunoglobulin injections, and ignorance of recommendations. Conclusions. - The higher the tetanic risk, the less recommendations were observed. A quick diagnostic test and a better availability of new easier to memorize recommendations should help GPs optimize their practices. (C) 2011 Published by Elsevier Masson SAS.

引用

页码：424 / 429

页数：6

共 20 条

[1]

Antona D, 2003, Euro Surveill, V8, P139

[2]

Antona D, 2008, B EPIDEMIOL HEBD, V30-31, P273

[3]

Ciroldi M, 1999, Rev Prat, V49, P2145

[4] Diagnosis of tetanus immunization status: Multicenter assessment of a rapid biological test [J].

Colombet, I ;

Saguez, C ;

Sanson-Le Pors, MJ ;

Coudert, B ;

Chatellier, G ;

Espinoza, P .

CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2005, 12 (09) :1057-1062

[5] Pooled plasma derivatives and Creutzfeldt-Jakob disease [J].

Creange, A ;

Gray, F ;

Cesaro, P ;

Degos, JD .

LANCET, 1996, 347 (8999) :482-482

[6]

DESLANDES JC, 2001, URG PRAT, V49, P50

[7]

*DIR GEN SANT COM, 1999, GUID VACC, P148

[8]

Direction Generale de la Sante Comite Technique des Vaccinations, 2008, GUID VACC, P339

[9]

DUMERY S, 2001, IMPACT MED, V559, P44

[10]

Elkharrat D, 1999, Am J Ther, V6, P203, DOI 10.1097/00045391-199907000-00005

← 1 2 →